CJC-1295 is a synthetic peptide designed to stimulate the release of growth hormone by acting on growth hormone–releasing hormone (GHRH) receptors in the pituitary gland. Instead of being growth hormone itself, it encourages the body to produce more of its own natural growth hormone, which can then increase insulin-like growth factor 1 (IGF-1) levels. It is commonly discussed in research and performance settings for its potential to support muscle growth, recovery, sleep quality, and fat metabolism. Some versions, especially CJC-1295 with DAC, are modified to stay active in the body longer, extending their half-life and duration of effect.
CJC-1295 is a synthetic peptide designed to stimulate the release of growth hormone by acting on growth hormone–releasing hormone (GHRH) receptors in the pituitary gland. Instead of being growth hormone itself, it encourages the body to produce more of its own natural growth hormone, which can then increase insulin-like growth factor 1 (IGF-1) levels. It is commonly discussed in research and performance settings for its potential to support muscle growth, recovery, sleep quality, and fat metabolism. Some versions, especially CJC-1295 with DAC, are modified to stay active in the body longer, extending their half-life and duration of effect.
Image 1 of 1